AspireAssist device

From Aaushi
Jump to navigation Jump to search

Indications

* more effective than counseling alone[2]

Adverse effects

Procedure

  • endoscopic insertion of a tube into the stomach via a small incision in the abdomen
  • a disk-shaped port valve that lies outside the body, flush against the skin of the abdomen, is connected to the tube & remains in place
  • ~20-30 minutes after meal consumption, an external connector & tubing is attached to the port valve
    • the port valve is opened & the contents drained into a toilet - this takes ~5-10 minutes[1]

Mechanism of action

More general terms

References

  1. 1.0 1.1 1.2 1.3 FDA News Release. June 14, 2016 FDA approves AspireAssist obesity device. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm506625.htm
  2. 2.0 2.1 2.2 2.3 2.4 Thompson CC, Abu Dayyeh BK Kushner R et al. Percutaneous gastrostomy device for the treatment of class II and class III obesity: Results of a randomized controlled trial. Am J Gastroenterol 2017 Mar; 112:447 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27922026